Inventor · disambiguated record
Edward Savory
Also filed as: SAVORY EDWARD · SAVORY EDWARD D · SAVORY EDWARD DANIEL
30 granted patents·19 pending applications·85 citations·filing 2004–2022
96Inventor score
Files withPROXIMAGEN LTD18PROXIMAGEN LLC10BENEVOLENTAI CAMBRIDGE LTD5CBT DEV LTD3SAVORY EDWARD DANIEL3
Top patents by PatentIndex Score
49 records- 0191US9951068B2Imidazo[4,5-C]pyridine and pyrrolo[2,3-C]pyridine derivatives as SSAO inhibitorsPROXIMAGEN LTD·Filed 2017·Granted Apr 24, 2018·8 cites·21 claims
- 0291US9676769B2Imidazo[4,5-C]pyridine and pyrrolo[2,3-C]pyridine derivatives as SSAO inhibitorsPROXIMAGEN LTD·Filed 2014·Granted Jun 13, 2017·11 cites·9 claims
- 0391US9428498B2Substituted imidazo[4,5-c]pyridine compounds and compositions thereofPROXIMAGEN LTD·Filed 2014·Granted Aug 30, 2016·11 cites·16 claims
- 0490US10428066B2Imidazo[4,5-C]pyridine and pyrrolo[2,3-C]pyridine derivatives as SSAO inhibitorsPROXIMAGEN LLC·Filed 2018·Granted Oct 1, 2019·6 cites·25 claims
- 0588US10995091B2CXCR4 receptor antagonistsPROXIMAGEN LLC·Filed 2018·Granted May 4, 2021·3 cites·14 claims
- 0686US10968223B2Imidazo[4,5-c]pyridine and pyrrolo[2,3-c]pyridine derivatives as SSAO inhibitorsPROXIMAGEN LLC·Filed 2020·Granted Apr 6, 2021·1 cites·24 claims
- 0785US10590125B2CompoundsPROXIMAGEN LLC·Filed 2016·Granted Mar 17, 2020·3 cites·9 claims
- 0885US10155761B2CXCR4 receptor antagonistsPROXIMAGEN LLC·Filed 2017·Granted Dec 18, 2018·4 cites·16 claims
- 0984US11512082B2Substituted imidazo[4,5-c]pyridine compounds and compositions thereofPROXIMAGEN LLC·Filed 2020·Granted Nov 29, 2022·1 cites·20 claims
- 1083US10065954B2Substituted imidazo[4,5-c]pyridines as SSAO inhibitorsPROXIMAGEN LTD·Filed 2015·Granted Sep 4, 2018·5 cites·17 claims
- 1183US9353086B2CXCR4 receptor antagonistsSAVORY EDWARD DANIEL·Filed 2011·Granted May 31, 2016·6 cites·17 claims
- 1283US8263616B24,5,6,7-tetrahydroimidazo[4,5-c]pyridine compoundsSAVORY EDWARD DANIEL·Filed 2009·Granted Sep 11, 2012·5 cites·7 claims
- 1382US2023110165A1Substituted Imidazo[4,5-c]pyridine Compounds and Compositions ThereofPROXIMAGEN LLC·Filed 2022·Application pending·0 cites
- 1480US10766897B2Imidazo[4,5-c]pyridine and pyrrolo[2,3-c]pyridine derivatives as SSAO inhibitorsPROXIMAGEN LLC·Filed 2019·Granted Sep 8, 2020·1 cites·27 claims
- 1580US9493457B24,5,6,7-tetrahyroimidazo[4,5-c]pyridine compoundsPROXIMAGEN LTD·Filed 2015·Granted Nov 15, 2016·2 cites·8 claims
- 1678US8633318B2Compounds for treatment or prevention of inflammation, an inflammatory disease, or an immune or an autoimmune disorderSAVORY EDWARD DANIEL·Filed 2009·Granted Jan 21, 2014·3 cites·7 claims
- 1776US9890160B2Compounds IPROXIMAGEN LTD·Filed 2016·Granted Feb 13, 2018·1 cites·16 claims
- 1875US7807685B2Therapeutic compoundsCBT DEV LTD·Filed 2007·Granted Oct 5, 2010·4 cites·5 claims
- 1973US9035066B2Method of using 4,5,6,7-tetrahydroimidazo[4,5-C]pyridine compoundsPROXIMAGEN LTD·Filed 2013·Granted May 19, 2015·1 cites·20 claims
- 2072US8569338B2Methods of using 4, 5, 6, 7-tetrahydroimidazo-[4,5-c]pyridine compoundsSAVORY EDWARD·Filed 2012·Granted Oct 29, 2013·2 cites·15 claims
- 2172US2022348577A1CXCR4 Receptor AntagonistsPROXIMAGEN LLC·Filed 2021·Application pending·0 cites
- 2271US9499510B2Pro-drug compoundsPROXIMAGEN LTD·Filed 2013·Granted Nov 22, 2016·3 cites·16 claims
- 2371US7906518B2Therapeutic compoundsCBT DEV LTD·Filed 2007·Granted Mar 15, 2011·1 cites·3 claims
- 2467US11530208B2Imidazo[4,5-C]pyridine derived SSAO inhibitorsPROXIMAGEN LLC·Filed 2015·Granted Dec 20, 2022·1 cites·16 claims
- 2567US11040969B2Compounds IBENEVOLENTAI CAMBRIDGE LTD·Filed 2019·Granted Jun 22, 2021·0 cites·6 claims
- 2666US9150574B2Enzyme inhibitor compoundsEVANS DAVID·Filed 2011·Granted Oct 6, 2015·1 cites·12 claims
- 2765US9227967B2Inhibitor compounds of semicarbazide-sensitive amine oxidasesEVANS DAVID·Filed 2011·Granted Jan 5, 2016·1 cites·37 claims
- 2863US10399973B2Compounds IBENEVOLENTAI CAMBRIDGE LTD·Filed 2017·Granted Sep 3, 2019·0 cites·12 claims
- 2959US2012010188A1Imidazopyridine CompoundsNILSSON MARIANNE·Filed 2009·Application pending·0 cites
- 3056US2016016929A1Pro-drug compoundsPROXIMAGEN LTD·Filed 2013·Application pending·0 cites
- 3156US2014275068A1Pro-drug compoundsPROXIMAGEN LTD·Filed 2014·Application pending·0 cites
- 3253US2016046606A1CXCR4 Receptor AntagonistsPROXIMAGEN LTD·Filed 2015·Application pending·0 cites
- 3353US2014206662A1Imidazopyridine CompoundsPROXIMAGEN LTD·Filed 2014·Application pending·0 cites
- 3452US2014107150A1New Compounds IIPROXIMAGEN LTD·Filed 2013·Application pending·0 cites
- 3551US2009131651A1Synthesis of 2-substituted adenosinesBROWN GILES ALBERT·Filed 2004·Application pending·0 cites
- 3650US10988473B2Process for the preparation of (3S,4S)-tetrahydrofuran-3-yl 4-isopropyl-6,7-dihydro-3H-imidazo[4,5-C]pyridine-5(4H)-carboxylateBENEVOLENTAI CAMBRIDGE LTD·Filed 2017·Granted Apr 27, 2021·0 cites·20 claims
- 3750US2008262214A1Synthesis of 2-Substituted AdenosinesCAMBRIDGE BIOTECHNOLOGY LTD·Filed 2004·Application pending·0 cites
- 3849US2016115147A1Pro-drug compoundsPROXIMAGEN LTD·Filed 2016·Application pending·0 cites
- 3948US2016318891A1Tonabersat prodrugsPROXIMAGEN LTD·Filed 2014·Application pending·0 cites
- 4047US7820811B2Pro-drugs of adenosine receptor agonistsCBT DEV LTD·Filed 2007·Granted Oct 26, 2010·0 cites·5 claims
- 4146US2016318892A1Prodrug compoundsPROXIMAGEN LTD·Filed 2014·Application pending·0 cites
- 4243US10316034B2Pharmaceutical salt forms of an inhibitor of semicarbazide-sensitive amine oxidase (SSAO)BENEVOLENTAI CAMBRIDGE LTD·Filed 2016·Granted Jun 11, 2019·0 cites·8 claims
- 4343US2015239905A1Imidazopyridine compoundsPROXIMAGEN LTD·Filed 2015·Application pending·0 cites
- 4442US2023002346A1New compounds and methodsBENEVOLENTAL BIO LTD·Filed 2020·Application pending·0 cites
- 4542US2008221060A1Therapeutic CompoundsPRITCHARD MARTYN·Filed 2005·Application pending·0 cites
- 4640US2015258101A1New compoundsPROXIMAGEN LTD·Filed 2015·Application pending·0 cites
- 4738US10369139B2Crystalline compound as semicarbazide-sensitive amine oxidase (SSAO) enzyme inhibitorBENEVOLENTAI CAMBRIDGE LTD·Filed 2016·Granted Aug 6, 2019·0 cites·18 claims
- 4833US2013324556A1Protease Activated Receptor 2 (PAR2) AntagonistsBOYD JOE WILLIAM·Filed 2012·Application pending·0 cites
- 4933US2013252951A17-hydroxy-pyrazolo[1,5-a] pyrimidine compounds and their use as ccr2 receptor antagonistsBOYD JOE WILLIAM·Filed 2011·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Edward Savory files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →